| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 10.594 | 7.192 | 12.245 | 13.255 | 13.435 | 15.471 |
| Total Income - EUR | - | - | - | - | 10.594 | 7.192 | 12.245 | 13.255 | 13.435 | 15.471 |
| Total Expenses - EUR | - | - | - | - | 9.879 | 8.093 | 9.146 | 13.861 | 20.519 | 17.981 |
| Gross Profit/Loss - EUR | - | - | - | - | 716 | -901 | 3.100 | -606 | -7.084 | -2.510 |
| Net Profit/Loss - EUR | - | - | - | - | 481 | -1.116 | 2.732 | -996 | -7.084 | -2.958 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nnsi Bogdan Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 26 | 13 | 12 | 28.121 | 20.726 | 13.340 |
| Current Assets | - | - | - | - | 1.010 | 500 | 5.056 | 5.328 | 1.978 | 3.783 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 21 | 47 |
| Receivables | - | - | - | - | 0 | 268 | 262 | 4.568 | 144 | 0 |
| Cash | - | - | - | - | 1.010 | 232 | 4.793 | 760 | 1.813 | 3.736 |
| Shareholders Funds | - | - | - | - | 523 | -602 | 2.144 | 1.154 | -5.934 | -8.858 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 512 | 1.114 | 2.925 | 32.296 | 28.638 | 25.981 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nnsi Bogdan Med S.r.l.